Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL

Human cytomegalovirus (CMV) causes significant disease in immunocompromised patients and serious birth defects if acquired in utero. Available CMV antivirals target the viral DNA polymerase, have significant toxicities, and suffer from resistance. New drugs targeting different pathways would be bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Zohaib, Al-Mahdi, Zainab, Zhu, Yali, McKee, Zachary, Parris, Deborah S., Parikh, Hardik I., Kellogg, Glen E., Kuchta, Alison, McVoy, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289655/
https://www.ncbi.nlm.nih.gov/pubmed/25499125
http://dx.doi.org/10.1016/j.antiviral.2014.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289655/
https://www.ncbi.nlm.nih.gov/pubmed/25499125
http://dx.doi.org/10.1016/j.antiviral.2014.12.003

Ejemplares similares